Physician profile
Stuart E Sheifer
NPI 1285638528
$1,686.61
in general payments reported to CMS, 2019-2025
16 companies · $18.77 in 2025
The $18.77 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,322 · 2020: $219 · 2021: $63.25 · 2022: $25.24 · 2024: $38.22 · 2025: $18.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $56.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $56.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $374.10 | 2019-2022 | |
| Amgen INC. | $255.19 | 2019-2021 | |
| Pfizer INC. | $136.84 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $136.10 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $127.65 | 2019 | |
| Janssen Pharmaceuticals, INC | $113.59 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $92.68 | 2019 | |
| Amarin Pharma, INC. | $78.90 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.57 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $68.12 | 2019-2021 | |
| Lundbeck LLC | $62.70 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $58.76 | 2019-2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.95 | 2019-2020 | |
| Astellas Pharma US INC | $23.62 | 2019 | |
| Gilead Sciences, INC. | $16.96 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $14.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Sheifer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.